These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The long-term significance of microscopic dural invasion in 354 patients with pituitary adenomas treated with transsphenoidal surgery. Meij BP; Lopes MB; Ellegala DB; Alden TD; Laws ER J Neurosurg; 2002 Feb; 96(2):195-208. PubMed ID: 11838791 [TBL] [Abstract][Full Text] [Related]
6. [Transsphenoidal surgery of secretory and invasive pituitary adenomas (somatotropinoma or corticotropinoma)--own experiences]. Zieliński G; Podgórski JK; Koziarski A; Potakiewicz Z; Warczyńska A; Zgliczyński W; Makowska A Przegl Lek; 2004; 61(9):928-34. PubMed ID: 15803901 [TBL] [Abstract][Full Text] [Related]
7. Criteria of cure and follow-up of central hyperthyroidism due to thyrotropin-secreting pituitary adenomas. Losa M; Giovanelli M; Persani L; Mortini P; Faglia G; Beck-Peccoz P J Clin Endocrinol Metab; 1996 Aug; 81(8):3084-90. PubMed ID: 8768879 [TBL] [Abstract][Full Text] [Related]
14. Primary Medical Treatment of Thyrotropin-Secreting Pituitary Adenomas by First-Generation Somatostatin Analogs: A Case Study of Seven Patients. Rimareix F; Grunenwald S; Vezzosi D; Rivière LD; Bennet A; Caron P Thyroid; 2015 Aug; 25(8):877-82. PubMed ID: 26244412 [TBL] [Abstract][Full Text] [Related]
15. Immediate postoperative measurement of thyroid-stimulating hormone as an early predictor of remission in thyroid-stimulating hormone-secreting pituitary adenomas. Kim SH; Ku CR; Na M; Yoo J; Kim W; Jung IH; Kim KW; Moon JH; Kim D; Lee EJ; Kim SH; Kim EH J Neurosurg; 2021 Mar; 134(3):794-800. PubMed ID: 32168476 [TBL] [Abstract][Full Text] [Related]